tiprankstipranks
Trending News
More News >
Boston Scientific (BSX)
:BSX
US Market
Advertisement

Boston Scientific (BSX) Ratios

Compare
3,405 Followers

Boston Scientific Ratios

BSX's free cash flow for Q1 2025 was $0.69. For the 2025 fiscal year, BSX's free cash flow was decreased by $ and operating cash flow was $0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.45 1.32 1.51 1.48 1.82
Quick Ratio
0.88 0.82 1.02 1.10 1.45
Cash Ratio
0.14 0.18 0.24 0.45 0.47
Solvency Ratio
0.18 0.18 0.12 0.14 0.06
Operating Cash Flow Ratio
0.75 0.51 0.40 0.44 0.41
Short-Term Operating Cash Flow Coverage
4.91 4.71 76.30 7.16 116.00
Net Current Asset Value
$ -10.36B$ -9.09B$ -9.14B$ -9.29B$ -8.76B
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.27 0.29 0.29 0.31
Debt-to-Equity Ratio
0.53 0.49 0.53 0.57 0.62
Debt-to-Capital Ratio
0.35 0.33 0.35 0.36 0.38
Long-Term Debt-to-Capital Ratio
0.32 0.31 0.34 0.35 0.37
Financial Leverage Ratio
1.81 1.82 1.85 1.94 2.01
Debt Service Coverage Ratio
3.82 3.84 4.69 4.12 4.03
Interest Coverage Ratio
68.43 8.84 3.51 5.99 2.89
Debt to Market Cap
0.07 0.11 0.13 0.15 0.18
Interest Debt Per Share
7.95 6.72 6.82 6.88 6.99
Net Debt to EBITDA
3.01 2.50 3.05 2.99 5.17
Profitability Margins
Gross Profit Margin
68.27%69.49%68.44%68.37%64.59%
EBIT Margin
12.44%15.80%12.70%11.92%2.84%
EBITDA Margin
19.70%24.25%21.61%21.18%15.24%
Operating Profit Margin
17.02%16.45%13.00%17.19%10.53%
Pretax Profit Margin
16.22%13.94%9.00%9.05%-1.39%
Net Profit Margin
13.54%11.19%5.50%8.76%-1.41%
Continuous Operations Profit Margin
9.21%11.18%5.50%8.75%-0.82%
Net Income Per EBT
83.50%80.25%61.17%96.75%101.45%
EBT Per EBIT
95.30%84.72%69.19%52.67%-13.22%
Return on Assets (ROA)
6.24%4.53%2.15%3.23%-0.45%
Return on Equity (ROE)
11.78%8.26%3.97%6.26%-0.91%
Return on Capital Employed (ROCE)
8.97%7.76%5.75%7.31%3.85%
Return on Invested Capital (ROIC)
7.31%6.11%3.52%7.00%3.91%
Return on Tangible Assets
15.43%10.80%5.11%7.37%-0.94%
Earnings Yield
1.65%1.90%1.05%1.72%-0.27%
Efficiency Ratios
Receivables Turnover
6.87 6.39 6.44 6.69 6.47
Payables Turnover
5.85 4.61 4.64 4.74 6.84
Inventory Turnover
2.05 1.75 2.14 2.34 2.60
Fixed Asset Turnover
4.82 4.32 4.48 4.43 3.90
Asset Turnover
0.46 0.41 0.39 0.37 0.32
Working Capital Turnover Ratio
13.22 8.05 6.34 4.70 6.97
Cash Conversion Cycle
169.01 186.64 148.34 133.80 143.51
Days of Sales Outstanding
53.15 57.11 56.70 54.59 56.37
Days of Inventory Outstanding
178.30 208.67 170.24 156.29 140.49
Days of Payables Outstanding
62.44 79.13 78.60 77.08 53.35
Operating Cycle
231.45 265.78 226.93 210.88 196.86
Cash Flow Ratios
Operating Cash Flow Per Share
2.58 1.72 1.07 1.31 1.06
Free Cash Flow Per Share
1.94 1.17 0.64 0.93 0.80
CapEx Per Share
0.64 0.55 0.43 0.39 0.27
Free Cash Flow to Operating Cash Flow
0.75 0.68 0.60 0.70 0.75
Dividend Paid and CapEx Coverage Ratio
3.96 3.02 2.29 3.07 3.73
Capital Expenditure Coverage Ratio
4.06 3.13 2.49 3.38 4.01
Operating Cash Flow Coverage Ratio
0.33 0.26 0.16 0.20 0.16
Operating Cash Flow to Sales Ratio
0.21 0.18 0.12 0.16 0.15
Free Cash Flow Yield
1.88%2.03%1.38%2.18%2.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
60.77 52.73 94.83 58.04 -363.79
Price-to-Sales (P/S) Ratio
8.25 5.90 5.22 5.08 5.14
Price-to-Book (P/B) Ratio
6.85 4.36 3.77 3.63 3.32
Price-to-Free Cash Flow (P/FCF) Ratio
53.10 49.32 72.42 45.91 44.99
Price-to-Operating Cash Flow Ratio
39.93 33.56 43.37 32.31 33.77
Price-to-Earnings Growth (PEG) Ratio
2.71 0.38 -2.73 -0.07 3.53
Price-to-Fair Value
6.85 4.36 3.77 3.63 3.32
Enterprise Value Multiple
44.89 26.82 27.20 26.98 38.87
Enterprise Value
163.54B 92.62B 74.54B 67.95B 58.74B
EV to EBITDA
44.89 26.82 27.20 26.98 38.87
EV to Sales
8.84 6.50 5.88 5.72 5.93
EV to Free Cash Flow
56.92 54.39 81.56 51.63 51.89
EV to Operating Cash Flow
42.90 37.01 48.85 36.33 38.95
Tangible Book Value Per Share
-0.99 -0.59 -0.87 -1.04 -0.38
Shareholders’ Equity Per Share
15.02 13.27 12.29 11.69 10.82
Tax and Other Ratios
Effective Tax Rate
0.17 0.20 0.39 0.03 -0.01
Revenue Per Share
12.51 9.80 8.87 8.36 7.00
Net Income Per Share
1.69 1.10 0.49 0.73 -0.10
Tax Burden
0.83 0.80 0.61 0.97 1.01
Interest Burden
1.30 0.88 0.71 0.76 -0.49
Research & Development to Revenue
0.10 0.10 0.10 0.10 0.12
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.02 0.02 0.02 0.02
Income Quality
1.69 1.57 2.19 1.80 -18.39
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis